EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC BY-NC 4.0

Platelet and Monocyte Microvesicles as Potential Biomarkers of COVID-19 Severity: A Cross-Sectional Analysis

Nastasya Nunki iD, Yetti Hernaningsih iD, Puspa Wardhani iD, Asih Herawati iD, Narazah Mohd Yusoff iD, Emmanuel Jairaj Moses iD, Bambang Pujo Semedi iD

Annals of Laboratory Medicine · 01.09.2024 · 44 (5) · 392-400

DOI: 10.3343/alm.2023.0395 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Annals of Laboratory Medicine, online erschienen am 12.03.2024. Verfasst von Nastasya Nunki und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory Medicine Study Interest, Master Program of Basic Medical Science, Faculty of Medicine, Universitas Airlangga, Surabaya, East Java, Indones…. Hauptthemen laut MEDLINE: COVID-19, Monocytes, Fibrin Fibrinogen Degradation Products, Biomarkers. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Universitas Airlangga.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Coronavirus disease (COVID-19) induces inflammation, coagulopathy following platelet and monocyte activation, and fibrinolysis, resulting in elevated D-dimer levels. Activated platelets and monocytes produce microvesicles (MVs). We analyzed the differences in platelet and monocyte MV counts in mild, moderate, and severe COVID-19, as well as their correlation with D-dimer levels.

Methods

In this cross-sectional study, blood specimens were collected from 90 COVID-19 patients and analyzed for D-dimers using SYSMEX CS-2500. Platelet MVs (PMVs; PMVCD42b+ and PMVCD41a+), monocyte MVs (MMVs; MMVCD14+), and phosphatidylserine-binding annexin V (PS, AnnV+) were analyzed using a BD FACSCalibur instrument.

Results

PMV and MMV counts were significantly increased in COVID-19 patients. AnnV+ PMVCD42b+ and AnnV+ PMVCD41a+ cell counts were higher in patients with severe COVID-19 than in those with moderate clinical symptoms. The median (range) of AnnV+ PMVCD42b+ (MV/μL) in mild, moderate, and severe COVID-19 was 1,118.3 (328.1-1,910.5), 937.4 (311.4-2,909.5), and 1,298.8 (458.2-9,703.5), respectively (P =0.009). The median (range) for AnnV+ PMVCD41a+ (MV/μL) in mild, moderate, and severe disease was 885.5 (346.3-1,682.7), 663.5 (233.8-2,081.5), and 1,146.3 (333.3-10,296.6), respectively (P =0.007). D-dimer levels (ng/mL) weak correlated with AnnV+ PMVCD41a+ (P =0.047, r=0.258).

Conclusions

PMV PMVCD42b+ and PMVCD41a+ counts were significantly increased in patients with severe clinical symptoms, and PMVCD41a+ counts correlated with D-dimer levels. Therefore, MV counts can be used as a potential biomarker of COVID-19 severity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19MonocytesFibrin Fibrinogen Degradation ProductsBiomarkersBlood PlateletsSARS-CoV-2Cell-Derived MicroparticlesSeverity of Illness IndexHumansCross-Sectional StudiesFemaleMaleMiddle AgedAgedAdultPandemicsAged, 80 and over

Stichwörter der Autor:innen

Annexin VCD14CD41aCD42bCOVID-19D-dimerMicrovesicles

Substanzen

Fibrin Fibrinogen Degradation ProductsBiomarkersfibrin fragment D

Autor:innen und Institutionen

  • Laboratory Medicine Study Interest, Master Program of Basic Medical Science, Faculty of Medicine, Universitas Airlangga, Surabaya, East Java, Indonesia.
  • Department of Medical Laboratory Technology, Faculty of Health, Universitas Nahdlatul Ulama Surabaya, Surabaya, East Java, Indonesia.
  • Department of Clinical Pathology, Faculty of Medicine, Universitas Airlangga, Dr. Soetomo General Academic Teaching Hospital, Surabaya, East Java, Indonesia.
  • Institute of Tropical Disease, Universitas Airlangga, Surabaya, East Java, Indonesia.
  • Postgraduate School of Universitas Airlangga, Surabaya, East Java, Indonesia.
  • Clinical Pathology Specialist Program, Faculty of Medicine, Universitas Airlangga, Dr. Soetomo General Academic Teaching Hospital, Surabaya, East Java, Indonesia.

ORCID-Profile: Nastasya Nunki, Yetti Hernaningsih, Puspa Wardhani, Asih Herawati, Narazah Mohd Yusoff, Emmanuel Jairaj Moses, Bambang Pujo Semedi

Förderung

  • Universitas Airlangga

Zitieren

APA

Nunki, N., Hernaningsih, Y., Wardhani, P., Herawati, A., Mohd Yusoff, N., Moses, E. J., & Semedi, B. P. (2024). Platelet and Monocyte Microvesicles as Potential Biomarkers of COVID-19 Severity: A Cross-Sectional Analysis. Annals of Laboratory Medicine, 44(5), 392-400. https://doi.org/10.3343/alm.2023.0395

Vancouver

Nunki N, Hernaningsih Y, Wardhani P, Herawati A, Mohd Yusoff N, Moses EJ, et al. Platelet and Monocyte Microvesicles as Potential Biomarkers of COVID-19 Severity: A Cross-Sectional Analysis. Annals of Laboratory Medicine. 2024;44(5):392-400. doi:10.3343/alm.2023.0395

BibTeX
@article{Nunki2024,
  author = {Nunki, Nastasya and Hernaningsih, Yetti and Wardhani, Puspa and Herawati, Asih and Mohd Yusoff, Narazah and Moses, Emmanuel Jairaj and Semedi, Bambang Pujo},
  title = {Platelet and Monocyte Microvesicles as Potential Biomarkers of COVID-19 Severity: A Cross-Sectional Analysis},
  journal = {Annals of Laboratory Medicine},
  year = {2024},
  volume = {44},
  number = {5},
  pages = {392--400},
  doi = {10.3343/alm.2023.0395}
}
Kostenlos starten →